The Department of Health has published new guidance for funding excess treatment costs and subventions to clarify the directions set out in HSG(97)32. The guidance relates to non-commercial research studies eligible for entry onto the NIHR Clinical Research Network Portfolio database. Funding to cover these costs is allocated to PCTs as part of their overall revenue allocations however where the Excess Treatment Costs impacts unfairly on a very small number of NHS organisations and would risk services disruption to NHS services the chief investigator can apply for subvention.
You can find details of the original 1997 guidance and the new guidance at:
www.dh.gov.uk/en/PublicationsPolicyAndGuidance/DH_097628 |